Sort
40,608 grants matching “prostate cancer”
Human-like automated radiotherapy treatment planning via imitation learning
$592,773Steve Bin Jiang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Phase II Clinical trial of GTC in Men on Active Surveillance
$592,725Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer
$592,644Alan Pollack · University Of Miami School Of Medicine · U01 · FY2021 · CA
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository
$592,642Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA
Cellular impact of X-linked dyskeratosis congenita
$592,620U Thomas Meier · Albert Einstein College Of Medicine · R01 · FY2020 · HL
Improved Management of GBM by Integrating Imaging and Tissue Analysis
$592,568Sarah J. Nelson · University Of California, San Francisco · P01 · FY2014 · CA
MICROENVIRONMENT-PROGRAMMED METASTATIC PROSTATE CANCER STEM CELLS (MPCSCS)
$592,500The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2013 · Department of Defense
THE ROLE OF BMI1-ASSOCIATED LNCRNAS IN ADVANCED PROSTATE CANCER
$592,500Northwestern University · · FY2020 · Defense Health Agency
Adiposity and Outcomes of Clinically Localized Prostate Cancer
$592,478Vincent L Freeman · University Of Illinois At Chicago · R01 · FY2011 · CA
Biobehavioral Effects of Qigong for Prostate Cancer Survivors with Fatigue
$592,443Anita Y Kinney · University Of New Mexico Health Scis Ctr · R01 · FY2018 · CA
A Nested Case-Control Study of Prostate Carcinogenesis
$592,441Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2009 · ES
Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer
$592,252Mehmet Toner · Massachusetts General Hospital · U01 · FY2023 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$592,164Shan Zha · Columbia University Health Sciences · R01 · FY2025 · CA
THE ONCOGENIC ROLE OF WWP1 E3 UBIQUITIN LIGASE IN PROSTATE CANCER DEVELOPMENT
$592,139Albany Medical College · · FY2008 · Department of Defense
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes
$592,110Gavin Ha · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Reproductive and Developmental Toxicity of Dioxin
$592,106Richard E Peterson · University Of Wisconsin-Madison · R01 · FY2010 · ES
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
$592,024Karen M Emmons · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Colorectal Tumor Risk Prediction in the PLCO Trial
$591,978Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Computer Support for the Colon Cancer Screening in PLCO Cancer Screening Trials
$591,908William Lake · Information Management Services, Inc. · N02 · FY2010 · CA
THE CYTOPLASM TRANSLOCATION OF ANDROGEN RECEPTOR COFACTOR P44 AS A TARGET FOR PROSTATE CANCER TREATMENT
$591,772The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2012 · Department of the Army
Colorectal Neoplasia in SELECT Participants
$591,750M. Peter Lance · University Of Arizona · R01 · FY2007 · CA
Inhibitors of protein-protein interactions
$591,475Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Develop CEES-induced skin toxicity models and evaluate silibinin efficacy
$591,427Rajesh Agarwal · National Jewish Health · U54 · FY2010 · ES
Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer
$591,227Mehmet Toner · Massachusetts General Hospital · U01 · FY2024 · CA
MR Fingerprinting and Computerized Decision Support for Prostate Cancer
$591,080Vikas Gulani · Case Western Reserve University · R01 · FY2019 · CA